Lobby organisation
Eli Lilly and Company
Business / industry · Health & pharma · HQ: United States · Transparency Register entry
As of 9 September 2026, Eli Lilly and Company appears in 66 declared MEP meetings (42 different MEPs), most often with European People's Party.
In their own words
“Lilly is a leading innovative biopharmaceutical company that unites caring with discovery to make life better for people around the world. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. Headquartered in the US, Lilly has…”
Stated goals from the organisation's own Transparency Register filing.
Who they meet, and when
Which groups they meet
Share of this organisation's 66 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2021–2026. Bar length is relative to its busiest year (33 in 2024).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 15 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 18 Aug 2026 | Lukas Mandl | EU Biotech Act |
| 24 Jun 2026 | Ruggero Razza | Incontro conoscitivo su priorità SANT |
| 8 Jun 2026 | Tiemo Wölken | Biotech Act |
| 28 Apr 2026 | Ingeborg ter Laak | Biotech Act |
| 8 Apr 2026 | Laurent Castillo | Pharma |
| 19 Mar 2026 | Elena Nevado del Campo | Cardiovascular health |
| 18 Mar 2026 | Margarita de la Pisa Carrión | SANT COMMITTEE ONGOING WORK |
| 18 Mar 2026 | Anna Bryłka | diagnostics in Alzheimer’s disease |
| 17 Mar 2026 | Marcin Sypniewski | Alzheimer treatment and diagnostics |
| 17 Mar 2026 | Laurent Castillo | Pharma |
| 4 Mar 2026 | Nikos Papandreou | Health |
| 29 Jan 2026 | Jessica Polfjärd | Health policy |
| 13 Nov 2025 | Marta Temido | Saúde |
| 14 Oct 2025 | Nina Carberry | Alzheimers Research |
| 8 Oct 2025 | Victor Negrescu | AmCham EU Healthcare Committee Meeting |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.